Novartis AG (NOVN) Stock Statistics & Valuation Metrics

Novartis AG has a market cap or net worth of CHF246.66B. The enterprise value is CHF346.05B.

Novartis AG has 2,112,421,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novartis AG’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is 16.17%.

The current PE Ratio of Novartis AG is 21.6. Novartis AG’s PEG ratio is 0.66.

In the last 12 months, Novartis AG had revenue of 57.13B and earned 14.65B in profits. Earnings per share was 7.56.

In the last 12 months, operating cash flow was 19.03B and capital expenditures -2.27B, giving a free cash flow of 16.76B billion.

Novartis AG pays an annual dividend of CHF3.5, resulting in a dividend yield of 3.18%

Novartis AG upcoming earnings date is Apr 28, 2026, TBA (Confirmed).

Novartis AG as a current ratio of 1.12, with Debt / Equity ratio of 80.28%

In the past 12 months, Novartis AG has paid 2.50B in taxes.

Novartis AG EV to EBITDA ratio is 12.26, with an EV/FCF ratio of 15.93.

Novartis AG has CHF11.58B in cash and marketable securities with CHF37.01B in debt, giving a net cash position of -CHF25.43B billion.

Gross margin is 75.72%, with operating margin of 31.15%, and net profit margin of 25.64%.

The average price target for Novartis AG is CHF118.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy